Lv11
20 积分 2026-04-03 加入
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
2小时前
求助中
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
7小时前
已完结
Impact of Tirzepatide Therapy on Thyroid Disease: Understanding Risks and Emerging Insights
6天前
已完结
Is Statin Use Associated With Risk of Thyroid Diseases? Results of a Retrospective Cohort Study
21天前
已完结
Drug Repurposing for Reducing the Size of Benign Thyroid Nodules: A Systematic Review
21天前
已完结
Effects of Metformin Therapy on Thyroid Volume and Functions in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Single-center Prospective Study
22天前
已完结
Risk of thyroid cancer associated with glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A population‐based cohort study
22天前
已完结
Metformin and thyroid disease
22天前
已完结
Evaluating Thyroid Cancer Risk in Glucagon-like Peptide-1 Analog Users With Thyroid Nodules
1个月前
已完结
Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists
1个月前
已完结
皖公网安备34019202002308
